» Articles » PMID: 36809639

Drug Therapeutics Delivery to the Salivary Glands: Intraglandular and Intraductal Injections

Overview
Date 2023 Feb 22
PMID 36809639
Authors
Affiliations
Soon will be listed here.
Abstract

Salivary gland hypofunction and xerostomia following pathological conditions like Sjogren's syndrome or head and neck radiotherapy usually lead to tremendous impairment of oral health, speech, and swallowing. The use of systemic drugs to alleviate the symptoms of these conditions has been associated with various adverse effects. Techniques of local drug delivery to the salivary gland have grown enormously to address this problem properly. The techniques include intraglandular and intraductal injections. In this chapter, we will provide a review of the literature for both techniques while incorporating our lab experience in using them.

Citing Articles

A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents.

Farhadi M, Fadavi P, Mohebbi S, Taghizadeh-Hesary F BMC Cancer. 2024; 24(1):832.

PMID: 38992600 PMC: 11241784. DOI: 10.1186/s12885-024-12582-2.

References
1.
Almansoori A, Khentii N, Kim B, Kim S, Lee J . Mesenchymal Stem Cell Therapy in Submandibular Salivary Gland Allotransplantation: Experimental Study. Transplantation. 2019; 103(6):1111-1120. DOI: 10.1097/TP.0000000000002612. View

2.
Antoniades D, Harrison J, Epivatianos A, Papanayotou P . Treatment of chronic sialadenitis by intraductal penicillin or saline. J Oral Maxillofac Surg. 2004; 62(4):431-4. DOI: 10.1016/j.joms.2003.07.007. View

3.
Beilvert A, Faure F, Meddahi-Pelle A, Chaunier L, Guilois S, Chaubet F . A resorbable shape-memory starch-based stent for the treatment of salivary ducts under sialendoscopic surgery. Laryngoscope. 2013; 124(4):875-81. DOI: 10.1002/lary.24380. View

4.
Berk L . Systemic pilocarpine for treatment of xerostomia. Expert Opin Drug Metab Toxicol. 2008; 4(10):1333-40. DOI: 10.1517/17425255.4.10.1333. View

5.
Bushara K . Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands. Med Hypotheses. 1997; 48(4):337-9. DOI: 10.1016/s0306-9877(97)90103-1. View